Scarica l'app Stockscreener
189.90
1.35%
-2.60
Dopo l'orario di chiusura:
190.71
0.81
+0.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché AZN Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Astrazeneca Plc Borsa (AZN) Ultime notizie
Could This International ETF Be One of the Best Investments of 2026? - The Motley Fool
Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline - AOL.com
Astrazeneca (AZN) Dips More Than Broader Market: What You Should Know - Yahoo Finance Singapore
Dermatomyositis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Octapharma, Argenx, AstraZeneca, Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus Pharma, Holdings - Barchart
AstraZeneca (LSE:AZN) Valuation Insights After Recent Price Moves - Kalkine Media
AZN Stock Price and Chart — LSE:AZN - TradingView
AstraZeneca’s DURGA-4 CAR-T Study Puts New Pressure on Multiple Myeloma Rivals - TipRanks
AstraZeneca Advances Pediatric Symbicort Device Study, Supporting Long Term Respiratory Strategy - TipRanks
AstraZeneca (AZN) Refutes Takeover Speculation - GuruFocus
$100 Million AstraZeneca Deal Puts Chinese Biotech Jacobio on Path to Profit - Caixin Global
Abivax denies AstraZeneca takeover rumors reported by French media - Reuters
Abivax Denies La Lettre Report of AstraZeneca Exclusivity - marketscreener.com
Abivax Denies La Lettre Report of AstraZeneca Exclusivity, Bloomberg Reports - marketscreener.com
Van ECK Associates Corp Sells 72,809 Shares of AstraZeneca PLC $AZN - MarketBeat
SageView Advisory Group LLC Acquires New Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca (AZN) Enters Exclusive Agreement Boosting Abivax Sha - GuruFocus
BNP Paribas Financial Markets Increases Stock Position in AstraZeneca PLC $AZN - MarketBeat
Capital Research Global Investors Raises Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca in pole position to acquire Abivax - marketscreener.com
Morgan Stanley sees double-digit EPS growth for AstraZeneca PLC (AZN) - MSN
Morgan Stanley Sees Double-Digit EPS Growth for AstraZeneca PLC (AZN) - Insider Monkey
Franklin Resources Inc. Sells 1,585,664 Shares of AstraZeneca PLC $AZN - MarketBeat
Russell Investments Group Ltd. Has $66.19 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Position Boosted by Bank of Montreal Can - MarketBeat
In Brief: Jacobio/AZ’s JAB-23E73 Reports First Clinical Results For Pan-KRAS Inhibitors - Citeline News & Insights
AZN Stock Price, Quote & Chart | ASTRAZENECA PLC-SPONS ADR (NYSE:AZN) - ChartMill
Zoladex Market Is Booming Worldwide 2026-2033 | AstraZeneca, Pfizer, Ipsen, Novartis - openPR.com
AstraZeneca awards $3.4 million to US nonprofits to expand healthcare access - MSN
AstraZeneca schedules digital annual general meeting for April 9 - Investing.com South Africa
Joshua Jackson, Gritty urge fans to get checked for cancer early - Stock Titan
AstraZeneca schedules AGM for April 9, 2026 - Investing.com India
Causeway Capital Management LLC Raises Stock Position in AstraZeneca PLC $AZN - MarketBeat
Capital International Investors Sells 6,352,463 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Sold by Capital Group Private Client Services Inc. - MarketBeat
[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer) | AZN SEC FilingForm 6-K - Stock Titan
Capital International Inc. CA Buys 18,059 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca's Stock Ranks 395th in Trading Activity Amid Institutional Splits and 156% Dividend Yield - Bitget
First Trust Advisors LP Sells 103,714 Shares of AstraZeneca PLC $AZN - MarketBeat
Cresset Asset Management LLC Lowers Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu - marketscreener.com
AstraZeneca PLC $AZN Shares Sold by Victory Capital Management Inc. - MarketBeat
AstraZeneca (AZN) Achieves Priority Review for Enhertu in Breast Cancer Treatment - GuruFocus
AstraZeneca, Daiichi Sankyo Wins Priority Review for Enhertu for Breast Cancer - marketscreener.com
Brokers Offer Predictions for AstraZeneca FY2026 Earnings - MarketBeat
AstraZeneca (AZN) and Other Drugmakers Watch as Key FDA Official Resigns - GuruFocus
Natixis Advisors LLC Buys 262,465 Shares of AstraZeneca PLC $AZN - MarketBeat
Legacy Capital Group California Inc. Buys New Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Purchased by Guardian Capital LP - MarketBeat
AstraZeneca’s AZD5004 Formulation Trial: Early Data Point for Long-Term Pipeline Value - TipRanks
AstraZeneca executives receive vested shares under deferred bonus plan - Investing.com India
AstraZeneca CEO Pascal Soriot receives vested shares under performance plan - Investing.com UK
AstraZeneca awards share grants to CEO and CFO under company incentive plans - Investing.com Nigeria
AstraZeneca (AZN) CEO awarded 101,495 shares on AZPSP vesting - Stock Titan
AstraZeneca (NYSE: AZN) awards deferred bonus shares to leaders - Stock Titan
Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial - Proactive financial news
Longfellow Investment Management Co. LLC Makes New Investment in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Stock Holdings Raised by Orion Porfolio Solutions LLC - MarketBeat
AstraZeneca Executives Receive Vested Deferred Share Awards - TipRanks
AstraZeneca Grants Long-Term Share Awards to CEO and CFO - TipRanks
The Zacks Analyst Blog Highlights Exxon Mobil, Palantir, AstraZeneca, Gencor Industries and Hour Loop - Yahoo Finance
243,177 Shares in AstraZeneca PLC $AZN Purchased by Foresight Global Investors Inc. - MarketBeat
Top pharma companies racing to launch a weight-loss pill - Reuters
Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca - Yahoo Finance
Xencor falls on royalty row with AstraZeneca (XNCR:NASDAQ) - Seeking Alpha
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term - Yahoo Finance
AZN Stock News: Robbins LLP Reminds Investors of the Pending Lea - GuruFocus
HAP Trading LLC Sells 7,267 Shares of AstraZeneca PLC $AZN - MarketBeat
Mengis Capital Management Inc. Boosts Stock Position in AstraZeneca PLC $AZN - MarketBeat
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):